RASAGILINE

RASAGILINE was reported 11266 times

RASAGILINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DOPAMINE AGONIST WITHDRAWAL SYNDROME 9 0.1667
1 VOYEURISM 3 0.1579
2 SADISM 3 0.1304
3 HOOKWORM INFECTION 3 0.0882
4 MICROSLEEP 3 0.0750
5 INFUSION SITE HYPERTROPHY 2 0.0714
6 BEREAVEMENT 3 0.0652
7 PARAPHILIA 8 0.0615
8 SUPINE HYPERTENSION 11 0.0582
9 DOPAMINE DYSREGULATION SYNDROME 25 0.0561
10 BENIGN NEOPLASM OF ADRENAL GLAND 6 0.0400
11 OBSESSIVE-COMPULSIVE PERSONALITY DISORDER 10 0.0395
12 RESTING TREMOR 24 0.0372
13 JEALOUS DELUSION 9 0.0318
14 INFUSION SITE PAPULE 3 0.0316
15 IMPULSE-CONTROL DISORDER 63 0.0306
16 HYPERSEXUALITY 55 0.0301
17 SALIVA DISCOLOURATION 10 0.0299
18 FREEZING PHENOMENON 102 0.0275
19 ENTEROBIASIS 4 0.0268
20 CATHETER SITE INDURATION 5 0.0259
21 CATHETER SITE DISCOMFORT 2 0.0250
22 ON AND OFF PHENOMENON 135 0.0243
23 MESENTERIC ARTERY THROMBOSIS 9 0.0234
24 BASAL GANGLIA INFARCTION 8 0.0233
25 SERUM SEROTONIN INCREASED 8 0.0225
26 CEREBRAL HYPOPERFUSION 10 0.0215
27 CATHETER SITE NODULE 4 0.0209
28 DUODENAL NEOPLASM 2 0.0204
29 STEREOTYPY 19 0.0201
30 DELUSION OF REPLACEMENT 2 0.0200
31 STOMA SITE HYPERGRANULATION 12 0.0190
32 ELECTROCONVULSIVE THERAPY 2 0.0183
33 AMIMIA 2 0.0182
34 COGWHEEL RIGIDITY 19 0.0181
35 BINOCULAR EYE MOVEMENT DISORDER 5 0.0174
36 PARKINSONIAN REST TREMOR 3 0.0159
37 DUPLICATE THERAPY ERROR 5 0.0156
38 CATHETER SITE BRUISE 5 0.0151
39 DELUSIONAL DISORDER, PERSECUTORY TYPE 6 0.0143
40 LORDOSIS 5 0.0142
41 STOMA SITE ERYTHEMA 26 0.0139
42 STOMA SITE DISCHARGE 38 0.0139
43 LACK OF SPONTANEOUS SPEECH 6 0.0137
44 SPINAL EPIDURAL HAEMATOMA 8 0.0136
45 MIXED ANXIETY AND DEPRESSIVE DISORDER 5 0.0135
46 STOMA SITE ODOUR 3 0.0134
47 PLEUROTHOTONUS 12 0.0133
48 CATHETER SITE MASS 2 0.0132
49 NEUROSYPHILIS 2 0.0132
50 CEREBELLAR STROKE 5 0.0128
51 DELUSION OF PARASITOSIS 2 0.0127
52 ORTHOSTATIC INTOLERANCE 9 0.0125
53 STICKY SKIN 5 0.0125
54 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 5 0.0124
55 NASAL MUCOSAL DISCOLOURATION 2 0.0124
56 ACTION TREMOR 2 0.0123
57 STOMA SITE INFECTION 16 0.0123
58 SOMATIC DELUSION 3 0.0122
59 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 6 0.0120
60 CATHETER SITE IRRITATION 4 0.0120
61 REDUCED FACIAL EXPRESSION 12 0.0118
62 GASTROINTESTINAL HYPERMOTILITY 5 0.0117
63 DEEP BRAIN STIMULATION 7 0.0116
64 ATHETOSIS 2 0.0115
65 PARKINSONISM HYPERPYREXIA SYNDROME 2 0.0112
66 SPINAL CORD ABSCESS 3 0.0110
67 HYPERKINESIA 23 0.0108
68 POSTURAL TREMOR 3 0.0103
69 SINOATRIAL BLOCK 6 0.0101
70 THERAPEUTIC PRODUCT EFFECT VARIABLE 39 0.0100
71 FEAR OF FALLING 8 0.0098
72 COMPULSIVE SHOPPING 20 0.0097
73 PARKINSONIAN GAIT 6 0.0096
74 STOMA SITE PAIN 14 0.0095
75 HALLUCINATION, OLFACTORY 4 0.0092
76 WRONG DEVICE USED 6 0.0091
77 SLEEP TALKING 15 0.0088
78 GIARDIASIS 3 0.0088
79 ACIDOSIS HYPERCHLORAEMIC 5 0.0084
80 NEUROPSYCHOLOGICAL SYMPTOMS 5 0.0083
81 OPHTHALMIC VEIN THROMBOSIS 2 0.0083
82 CORONARY ARTERY DISSECTION 7 0.0081
83 MYOGLOBIN URINE PRESENT 2 0.0081
84 INFUSION SITE ABSCESS 4 0.0079
85 PATIENT DISSATISFACTION WITH DEVICE 2 0.0079
86 AUTOPHOBIA 2 0.0079
87 GAMBLING DISORDER 21 0.0078
88 SUICIDE THREAT 3 0.0077
89 BRADYKINESIA 45 0.0076
90 AUTONOMIC NERVOUS SYSTEM IMBALANCE 22 0.0075
91 DYSKINESIA 304 0.0075
92 STOMA SITE IRRITATION 4 0.0074
93 DEMENTIA WITH LEWY BODIES 8 0.0072
94 LUMBAR RADICULOPATHY 8 0.0069
95 ORTHOSTATIC HYPERTENSION 4 0.0069
96 INFUSION SITE INDURATION 10 0.0067
97 DELUSIONAL DISORDER, UNSPECIFIED TYPE 5 0.0067
98 CATHETER SITE RELATED REACTION 5 0.0067
99 POST THROMBOTIC SYNDROME 3 0.0067
100 PATHOLOGICAL GAMBLING 11 0.0066
101 BINGE EATING 7 0.0065
102 UTERINE PROLAPSE 7 0.0064
103 LIBIDO INCREASED 13 0.0064
104 HALLUCINATION, VISUAL 135 0.0064
105 INTERMITTENT CLAUDICATION 10 0.0063
106 PRODUCT RESIDUE PRESENT 34 0.0063
107 MEDICAL DEVICE SITE DISCOMFORT 5 0.0062
108 DRUG EFFECT VARIABLE 7 0.0062
109 LUNG PERFORATION 2 0.0060
110 HYPORESPONSIVE TO STIMULI 7 0.0060
111 AKINESIA 12 0.0058
112 SEROTONIN SYNDROME 111 0.0058
113 ANTICHOLINERGIC SYNDROME 9 0.0056
114 MUSCLE RIGIDITY 65 0.0054
115 DELUSION 82 0.0053
116 COLITIS MICROSCOPIC 25 0.0053
117 INFUSION SITE NODULE 5 0.0052
118 STOMA SITE HAEMORRHAGE 8 0.0052
119 DROPPED HEAD SYNDROME 2 0.0051
120 HALLUCINATION 379 0.0050
121 GASTROINTESTINAL POLYP HAEMORRHAGE 3 0.0050
122 DEVICE COLOUR ISSUE 2 0.0050
123 MASKED FACIES 2 0.0049
124 INFUSION SITE DISCOMFORT 5 0.0048
125 HYPOSMIA 7 0.0047
126 IMPULSIVE BEHAVIOUR 17 0.0045
127 COMPULSIONS 3 0.0045
128 HALLUCINATION, TACTILE 3 0.0045
129 YAWNING 12 0.0045
130 STOMA SITE REACTION 3 0.0044
131 NONSPECIFIC REACTION 24 0.0044
132 TRAUMATIC INTRACRANIAL HAEMORRHAGE 4 0.0044
133 DISINHIBITION 7 0.0043
134 INFUSION SITE INFLAMMATION 3 0.0042
135 DYSTONIA 82 0.0042
136 HALLUCINATIONS, MIXED 17 0.0040
137 STOMA SITE INFLAMMATION 3 0.0040
138 DROOLING 27 0.0039
139 CREATINE KINASE INCREASED 3 0.0039
140 INTENTIONAL UNDERDOSE 28 0.0038
141 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 10 0.0038
142 URETEROLITHIASIS 4 0.0038
143 DEVICE CONNECTION ISSUE 8 0.0038
144 INFUSION SITE CELLULITIS 2 0.0038
145 MEDICAL DEVICE CHANGE 2 0.0038
146 MYOGLOBINURIA 2 0.0038
147 CATHETER SITE ERYTHEMA 8 0.0037
148 COMPULSIVE SEXUAL BEHAVIOUR 3 0.0037
149 DEVICE OCCLUSION 52 0.0037
150 DEPRESSIVE SYMPTOM 13 0.0037
151 QUADRIPARESIS 6 0.0036
152 DERMATILLOMANIA 2 0.0034
153 SALIVA ALTERED 3 0.0033
154 SINUS NODE DYSFUNCTION 6 0.0033
155 PNEUMOPERITONEUM 6 0.0032
156 NOCTURIA 39 0.0032
157 CATHETER SITE SWELLING 3 0.0032
158 MONOCLONAL GAMMOPATHY 2 0.0032
159 PRODUCT USED FOR UNKNOWN INDICATION 4 0.0032
160 BLADDER CATHETERISATION 3 0.0031
161 MOTOR DYSFUNCTION 31 0.0030
162 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 2 0.0030
163 FEELING GUILTY 4 0.0030
164 ILLUSION 5 0.0030
165 INFUSION SITE INFECTION 7 0.0030
166 CEREBRAL ATROPHY 12 0.0030
167 MUSCLE CONTRACTURE 6 0.0030
168 STOMA COMPLICATION 3 0.0030
169 PSYCHOTIC SYMPTOM 6 0.0029
170 NASAL DISCHARGE DISCOLOURATION 4 0.0029
171 RADIOISOTOPE SCAN ABNORMAL 2 0.0028
172 PERSECUTORY DELUSION 7 0.0028
173 DEVICE INEFFECTIVE 3 0.0028
174 INFUSION SITE BRUISING 6 0.0028
175 LABELLED DRUG-DRUG INTERACTION ISSUE 4 0.0028
176 FINE MOTOR SKILL DYSFUNCTION 8 0.0028
177 OROMANDIBULAR DYSTONIA 2 0.0027
178 DEVICE KINK 10 0.0027
179 WHEELCHAIR USER 12 0.0027
180 CATHETER SITE PAIN 7 0.0027
181 CATHETER SITE DISCHARGE 3 0.0027
182 HYPERTHERMIA 20 0.0026
183 DISTRACTIBILITY 3 0.0026
184 SOMNAMBULISM 17 0.0026
185 MICTURITION URGENCY 29 0.0025
186 DEVICE DAMAGE 2 0.0025
187 WEIGHT ABNORMAL 6 0.0025
188 EXCESSIVE GRANULATION TISSUE 2 0.0025
189 APPLICATION SITE HYPERSENSITIVITY 3 0.0025
190 ORTHOSTATIC HYPOTENSION 43 0.0025
191 INFUSION SITE REACTION 7 0.0023
192 GINGIVAL ERYTHEMA 2 0.0023
193 DEVICE LOOSENING 2 0.0023
194 PRODUCT PACKAGING DIFFICULT TO OPEN 6 0.0023
195 CATHETER SITE PRURITUS 2 0.0023
196 ABNORMAL SLEEP-RELATED EVENT 3 0.0023
197 EXTRADURAL HAEMATOMA 3 0.0023
198 NUCHAL RIGIDITY 2 0.0022
199 AGORAPHOBIA 3 0.0022
200 THERAPEUTIC PRODUCT EFFECT DELAYED 10 0.0022
201 FOOD INTOLERANCE 8 0.0022
202 PNEUMONIA KLEBSIELLA 4 0.0022
203 HYPERPYREXIA 9 0.0021
204 GASTROINTESTINAL MOTILITY DISORDER 11 0.0021
205 SPINAL CORD COMPRESSION 8 0.0021
206 PARKINSONISM 20 0.0020
207 NEUROLEPTIC MALIGNANT SYNDROME 24 0.0020
208 DIPLEGIA 4 0.0020
209 MICTURITION DISORDER 7 0.0020
210 THROMBOPHLEBITIS 7 0.0020
211 DRUG EFFECT DELAYED 9 0.0020
212 INTERVERTEBRAL DISC COMPRESSION 2 0.0019
213 HYPOMANIA 7 0.0019
214 HYPOPERFUSION 2 0.0019
215 SLEEP DEFICIT 4 0.0019
216 POSTURE ABNORMAL 6 0.0018
217 INFUSION SITE MASS 2 0.0018
218 SHOULDER FRACTURE 3 0.0018
219 CHOKING 35 0.0018
220 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 4 0.0018
221 CONTRAINDICATED PRODUCT PRESCRIBED 3 0.0018
222 PERONEAL NERVE PALSY 10 0.0018
223 DIZZINESS POSTURAL 17 0.0018
224 SKIN LACERATION 19 0.0017
225 OBSESSIVE-COMPULSIVE DISORDER 14 0.0017
226 CHOREA 3 0.0017
227 PARANOIA 30 0.0017
228 HYPERREFLEXIA 6 0.0017
229 GAMBLING 2 0.0017
230 DELIRIUM 59 0.0017
231 DECREASED INTEREST 10 0.0017
232 LABILE BLOOD PRESSURE 2 0.0017
233 REFLUX GASTRITIS 2 0.0017
234 BLADDER PROLAPSE 2 0.0016
235 MEDICAL DEVICE DISCOMFORT 5 0.0016
236 INFUSION SITE WARMTH 2 0.0016
237 BALANCE DISORDER 141 0.0016
238 HOMICIDE 3 0.0016
239 DYSENTERY 3 0.0016
240 CATHETER SITE HAEMORRHAGE 4 0.0016
241 CATHETER SITE INFECTION 6 0.0016
242 DRUG TOLERANCE 8 0.0016
243 PARKINSON'S DISEASE 4 0.0016
244 REHABILITATION THERAPY 6 0.0015
245 RESPIRATORY ACIDOSIS 6 0.0015
246 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
247 DEMENTIA 42 0.0015
248 POTENTIATING DRUG INTERACTION 5 0.0015
249 DEVICE USE ISSUE 26 0.0015
250 SKIN ABRASION 7 0.0015
251 BEHAVIOUR DISORDER 8 0.0015
252 SPUTUM DISCOLOURED 14 0.0015
253 INFUSION SITE RASH 2 0.0015
254 CHEST INJURY 3 0.0014
255 IMPAIRED SELF-CARE 3 0.0014
256 THERAPEUTIC RESPONSE SHORTENED 48 0.0014
257 LIVEDO RETICULARIS 3 0.0014
258 TREMOR 228 0.0014
259 LUMBAR SPINAL STENOSIS 4 0.0014
260 TRISMUS 7 0.0014
261 GASTROINTESTINAL ULCER 3 0.0014
262 POOR QUALITY SLEEP 29 0.0013
263 SPEECH DISORDER 70 0.0013
264 METABOLIC ENCEPHALOPATHY 4 0.0013
265 PSYCHOTIC DISORDER 39 0.0013
266 ABNORMAL LOSS OF WEIGHT 9 0.0013
267 MASTICATION DISORDER 4 0.0013
268 PALLIATIVE CARE 2 0.0013
269 DEVICE PHYSICAL PROPERTY ISSUE 10 0.0013
270 INFUSION SITE ERYTHEMA 11 0.0013
271 GASTROSTOMY 2 0.0013
272 COGNITIVE DISORDER 60 0.0013
273 DISCOURAGEMENT 3 0.0013
274 JAW DISORDER 7 0.0013
275 GASTROINTESTINAL STOMA COMPLICATION 2 0.0013
276 FOREIGN BODY IN THROAT 4 0.0013
277 GENERALISED TONIC-CLONIC SEIZURE 21 0.0013
278 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 13 0.0013
279 INHIBITORY DRUG INTERACTION 2 0.0013
280 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 11 0.0012
281 STARING 3 0.0012
282 FRUSTRATION TOLERANCE DECREASED 10 0.0012
283 INCOHERENT 8 0.0012
284 SLOW SPEECH 3 0.0012
285 BRADYPHRENIA 8 0.0012
286 CONFUSIONAL STATE 197 0.0012
287 INFUSION SITE HAEMORRHAGE 4 0.0012
288 LISTLESS 4 0.0012
289 NIGHTMARE 42 0.0012
290 HYPERVENTILATION 7 0.0012
291 SALIVARY HYPERSECRETION 12 0.0012
292 ABNORMAL DREAMS 33 0.0012
293 ATTENTION DEFICIT HYPERACTIVITY DISORDER 5 0.0012
294 DYSPHORIA 6 0.0012
295 MIDDLE INSOMNIA 22 0.0012
296 HYPOKINESIA 17 0.0012
297 PRODUCT DISPENSING ISSUE 5 0.0012
298 APHTHOUS ULCER 9 0.0012
299 IMMOBILE 5 0.0011
300 ERYTHEMA NODOSUM 4 0.0011
301 FALL 379 0.0011
302 INCONTINENCE 12 0.0011
303 FOOD INTERACTION 2 0.0011
304 IMPRISONMENT 2 0.0011
305 DRUG INTERACTION 179 0.0011
306 ANAL INCONTINENCE 10 0.0011
307 ABNORMAL BEHAVIOUR 44 0.0011
308 OBSESSIVE THOUGHTS 2 0.0011
309 AGITATION 81 0.0011
310 DEVICE ALARM ISSUE 2 0.0011
311 BODY TEMPERATURE ABNORMAL 2 0.0011
312 INJECTION SITE CELLULITIS 2 0.0011
313 INITIAL INSOMNIA 11 0.0011
314 BLADDER SPASM 2 0.0011
315 MOBILITY DECREASED 76 0.0011
316 CLAVICLE FRACTURE 4 0.0010
317 MOTION SICKNESS 2 0.0010
318 VOMITING PROJECTILE 3 0.0010
319 THERAPEUTIC PRODUCT INEFFECTIVE 4 0.0010
320 SEDATION 27 0.0010
321 DEVICE POWER SOURCE ISSUE 3 0.0010
322 DRUG LEVEL INCREASED 17 0.0010
323 NECK INJURY 3 0.0010
324 HALLUCINATION, AUDITORY 16 0.0010
325 DEFAECATION URGENCY 7 0.0010
326 HIP FRACTURE 32 0.0010
327 GAIT INABILITY 33 0.0010
328 PRESYNCOPE 24 0.0010
329 INGUINAL HERNIA 6 0.0010
330 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 70 0.0010
331 DYSARTHRIA 37 0.0010
332 DEVICE ISSUE 88 0.0010
333 PETIT MAL EPILEPSY 5 0.0010
334 PANIC REACTION 7 0.0010
335 ANOSMIA 14 0.0010
336 DEVICE DISLOCATION 42 0.0010
337 PSYCHOMOTOR HYPERACTIVITY 16 0.0010
338 RHABDOMYOLYSIS 40 0.0010
339 PHYSICAL ASSAULT 2 0.0010
340 LUNG ABSCESS 2 0.0010
341 ATRIAL TACHYCARDIA 2 0.0010
342 RESTLESS LEGS SYNDROME 17 0.0009
343 OCULOGYRIC CRISIS 2 0.0009
344 DEREALISATION 2 0.0009
345 DEPRESSED MOOD 49 0.0009
346 HIP SURGERY 5 0.0009
347 HYPOVENTILATION 3 0.0009
348 TROPONIN INCREASED 7 0.0009
349 PRESCRIBED UNDERDOSE 18 0.0009
350 DYSSTASIA 26 0.0009
351 DISTURBANCE IN ATTENTION 48 0.0009
352 GASTROINTESTINAL HYPOMOTILITY 2 0.0009
353 BRAIN OPERATION 2 0.0009
354 GAIT DISTURBANCE 167 0.0009
355 CERVICAL VERTEBRAL FRACTURE 3 0.0009
356 AGGRESSION 43 0.0009
357 DISORIENTATION 34 0.0009
358 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
359 POLYURIA 7 0.0009
360 APPLICATION SITE REACTION 6 0.0009
361 MANIA 14 0.0009
362 ENERGY INCREASED 5 0.0008
363 MOVEMENT DISORDER 27 0.0008
364 PRODUCT DISPENSING ERROR 18 0.0008
365 INJECTION SITE NODULE 9 0.0008
366 UNRESPONSIVE TO STIMULI 21 0.0008
367 SPINAL OPERATION 10 0.0008
368 HYPERTENSIVE CRISIS 9 0.0008
369 DEVICE INFUSION ISSUE 2 0.0008
370 HYPERACUSIS 3 0.0008
371 MENTAL DISORDER 35 0.0008
372 INJECTION SITE ABSCESS 2 0.0008
373 DYSPHAGIA 76 0.0008
374 GENERAL SYMPTOM 6 0.0008
375 CONSTIPATION 174 0.0008
376 PROTEIN TOTAL DECREASED 3 0.0008
377 BLEPHAROSPASM 5 0.0008
378 FACE INJURY 3 0.0008
379 HAEMORRHAGE URINARY TRACT 2 0.0008
380 BOWEL MOVEMENT IRREGULARITY 6 0.0008
381 ABDOMINAL INFECTION 2 0.0008
382 NEUTROPHIL COUNT INCREASED 8 0.0008
383 EUPHORIC MOOD 8 0.0008
384 PRODUCT COLOUR ISSUE 4 0.0008
385 INFUSION SITE PAIN 10 0.0008
386 SOMNOLENCE 156 0.0008
387 PANIC DISORDER 3 0.0008
388 HYPERSOMNIA 22 0.0008
389 BLOOD CREATINE PHOSPHOKINASE INCREASED 22 0.0008
390 EXFOLIATIVE RASH 2 0.0008
391 DYSGRAPHIA 5 0.0008
392 UROSEPSIS 7 0.0008
393 HEAD INJURY 24 0.0008
394 PERSONALITY CHANGE 7 0.0008
395 SENSORY DISTURBANCE 12 0.0007
396 VITAMIN B12 DEFICIENCY 3 0.0007
397 ERECTILE DYSFUNCTION 19 0.0007
398 APPLICATION SITE DISCOLOURATION 3 0.0007
399 MUSCULOSKELETAL DISORDER 14 0.0007
400 TACHYPNOEA 10 0.0007
401 PERIPHERAL VENOUS DISEASE 3 0.0007
402 HEAD DISCOMFORT 13 0.0007
403 GASTRIC PERFORATION 2 0.0007
404 FAECALOMA 4 0.0007
405 SELF-MEDICATION 3 0.0007
406 CHOKING SENSATION 4 0.0007
407 PNEUMONIA ASPIRATION 18 0.0007
408 SLEEP TERROR 3 0.0007
409 DISSEMINATED INTRAVASCULAR COAGULATION 10 0.0007
410 LIGAMENT SPRAIN 7 0.0007
411 HYPOPHAGIA 18 0.0007
412 HYPERTONIA 4 0.0007
413 BRAIN INJURY 7 0.0007
414 DIPLOPIA 18 0.0007
415 HYPERTONIC BLADDER 2 0.0007
416 TOOTH INJURY 3 0.0007
417 STRESS CARDIOMYOPATHY 4 0.0007
418 DYSPHEMIA 3 0.0007
419 RESTLESSNESS 25 0.0007
420 NEGATIVE THOUGHTS 2 0.0007
421 URINARY INCONTINENCE 20 0.0007
422 MUSCULOSKELETAL STIFFNESS 59 0.0007
423 MYOCLONUS 8 0.0007
424 ATYPICAL PNEUMONIA 2 0.0007
425 URINARY TRACT DISORDER 3 0.0007
426 CEREBROVASCULAR DISORDER 2 0.0007
427 TENSION 4 0.0007
428 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
429 DRY MOUTH 53 0.0007
430 ISCHAEMIC CARDIOMYOPATHY 2 0.0007
431 DERMATITIS ALLERGIC 8 0.0006
432 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
433 RIB FRACTURE 13 0.0006
434 FOOT DEFORMITY 7 0.0006
435 MYDRIASIS 8 0.0006
436 EPILEPSY 19 0.0006
437 SENSORY LOSS 5 0.0006
438 LIMB DISCOMFORT 19 0.0006
439 RETCHING 13 0.0006
440 INJECTION SITE INFECTION 2 0.0006
441 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
442 HYPERVOLAEMIA 3 0.0006
443 FOOT OPERATION 3 0.0006
444 EMBEDDED DEVICE 6 0.0006
445 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
446 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 2 0.0006
447 BLOOD PRESSURE ABNORMAL 12 0.0006
448 TERMINAL STATE 4 0.0006
449 CONDITION AGGRAVATED 181 0.0006
450 SLEEP DISORDER 42 0.0006
451 FEEDING DISORDER 12 0.0006
452 FEMORAL NECK FRACTURE 3 0.0006
453 WRIST FRACTURE 7 0.0006
454 THERAPY NON-RESPONDER 26 0.0006
455 PULMONARY HYPERTENSION 12 0.0006
456 PARTIAL SEIZURES 3 0.0006
457 INCORRECT DOSE ADMINISTERED BY DEVICE 15 0.0006
458 ENCEPHALOPATHY 14 0.0006
459 GROIN PAIN 5 0.0006
460 JOINT DISLOCATION 6 0.0006
461 SUDDEN DEATH 6 0.0006
462 DUODENAL ULCER 4 0.0006
463 AGEUSIA 14 0.0006
464 BRUXISM 3 0.0006
465 TONGUE DISORDER 4 0.0006
466 URINARY TRACT INFECTION 94 0.0006
467 BRADYCARDIA 29 0.0005
468 PRODUCT PHYSICAL ISSUE 11 0.0005
469 PARADOXICAL DRUG REACTION 2 0.0005
470 BLOOD PRESSURE DECREASED 36 0.0005
471 BLOOD PRESSURE FLUCTUATION 13 0.0005
472 DEFORMITY 5 0.0005
473 MITRAL VALVE INCOMPETENCE 6 0.0005
474 PRODUCT DOSE OMISSION IN ERROR 15 0.0005
475 NEUTROPHILIA 3 0.0005
476 INSOMNIA 140 0.0005
477 HAEMODYNAMIC INSTABILITY 4 0.0005
478 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
479 COMMUNICATION DISORDER 2 0.0005
480 GASTRIC INFECTION 2 0.0005
481 HIP ARTHROPLASTY 8 0.0005
482 HYPERHIDROSIS 67 0.0005
483 PELVIC FRACTURE 4 0.0005
484 PERIPHERAL SWELLING 79 0.0005
485 SEXUAL DYSFUNCTION 6 0.0005
486 MEMORY IMPAIRMENT 70 0.0005
487 PROSTATOMEGALY 2 0.0005
488 PRODUCT DOSE OMISSION 33 0.0005
489 PRODUCT PRESCRIBING ERROR 12 0.0005
490 TRICUSPID VALVE INCOMPETENCE 4 0.0005
491 CARDIAC PACEMAKER INSERTION 3 0.0005
492 SUICIDAL IDEATION 46 0.0005
493 HYPERPHAGIA 2 0.0005
494 HYPOTONIA 5 0.0005
495 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 24 0.0005
496 HYPONATRAEMIA 28 0.0005
497 MENTAL IMPAIRMENT 12 0.0005
498 NEURALGIA 12 0.0005
499 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 23 0.0005
500 DECUBITUS ULCER 4 0.0005
501 SYNCOPE 49 0.0005
502 GENERAL PHYSICAL HEALTH DETERIORATION 56 0.0005
503 AORTIC DISSECTION 2 0.0005
504 THINKING ABNORMAL 9 0.0005
505 APPLICATION SITE IRRITATION 6 0.0005
506 APATHY 7 0.0005
507 HYPOTENSION 96 0.0005
508 ANXIETY 136 0.0005
509 COUGH 134 0.0005
510 INFUSION SITE SWELLING 3 0.0005
511 PHOTOPSIA 3 0.0005
512 PRODUCT DOSE OMISSION ISSUE 138 0.0005
513 DYSPHONIA 27 0.0005
514 MONOPLEGIA 2 0.0005
515 TENDON DISORDER 3 0.0005
516 BONE CANCER 2 0.0005
517 TREATMENT NONCOMPLIANCE 25 0.0005
518 NEUROTOXICITY 8 0.0005
519 TOOTH FRACTURE 5 0.0005
520 PRODUCT COMMUNICATION ISSUE 4 0.0005
521 DEVICE DIFFICULT TO USE 30 0.0005
522 DIZZINESS 226 0.0005
523 EXPIRED PRODUCT ADMINISTERED 15 0.0005
524 CATHETERISATION CARDIAC 2 0.0005
525 UNEVALUABLE EVENT 34 0.0004
526 SKIN MASS 3 0.0004
527 ADVERSE DRUG REACTION 40 0.0004
528 LEUKOCYTOSIS 8 0.0004
529 INTERNAL HAEMORRHAGE 5 0.0004
530 INJECTION SITE PAPULE 2 0.0004
531 FORMICATION 3 0.0004
532 FEELING COLD 12 0.0004
533 APHASIA 13 0.0004
534 FEELING OF DESPAIR 2 0.0004
535 PERFORMANCE STATUS DECREASED 2 0.0004
536 SKIN ULCER 11 0.0004
537 THERAPEUTIC RESPONSE UNEXPECTED 19 0.0004
538 EATING DISORDER 9 0.0004
539 POISONING DELIBERATE 4 0.0004
540 COMA 20 0.0004
541 FEELING JITTERY 8 0.0004
542 URINARY RETENTION 14 0.0004
543 PARALYSIS 6 0.0004
544 ANGER 14 0.0004
545 PRESCRIBED OVERDOSE 8 0.0004
546 HORMONE LEVEL ABNORMAL 2 0.0004
547 PSYCHIATRIC SYMPTOM 3 0.0004
548 APPLICATION SITE BURN 2 0.0004
549 DEPRESSED LEVEL OF CONSCIOUSNESS 16 0.0004
550 RESPIRATORY DISTRESS 11 0.0004
551 TENDON PAIN 3 0.0004
552 KLEBSIELLA INFECTION 2 0.0004
553 TASTE DISORDER 8 0.0004
554 DRY THROAT 4 0.0004
555 MUSCLE TWITCHING 9 0.0004
556 CACHEXIA 2 0.0004
557 FAILURE TO THRIVE 2 0.0004
558 PANIC ATTACK 14 0.0004
559 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 21 0.0004
560 AFFECTIVE DISORDER 3 0.0004
561 CATATONIA 2 0.0004
562 PRODUCT USE COMPLAINT 6 0.0004
563 SCIATICA 6 0.0004
564 FEELING ABNORMAL 90 0.0004
565 MALIGNANT MELANOMA 5 0.0004
566 JOINT RANGE OF MOTION DECREASED 5 0.0004
567 QUALITY OF LIFE DECREASED 5 0.0004
568 PRODUCT SIZE ISSUE 2 0.0004
569 STENT PLACEMENT 3 0.0004
570 GINGIVITIS 2 0.0004
571 PULMONARY THROMBOSIS 4 0.0004
572 ASPIRATION 4 0.0004
573 WHITE BLOOD CELL COUNT INCREASED 14 0.0004
574 DEPRESSION 83 0.0004
575 SUICIDE ATTEMPT 22 0.0004
576 PROSTATIC DISORDER 2 0.0004
577 VENTRICULAR FIBRILLATION 4 0.0004
578 ROAD TRAFFIC ACCIDENT 15 0.0004
579 ATRIAL SEPTAL DEFECT 3 0.0004
580 MALNUTRITION 4 0.0004
581 WEIGHT DECREASED 99 0.0004
582 CHROMATURIA 8 0.0004
583 MULTIPLE ORGAN DYSFUNCTION SYNDROME 10 0.0004
584 OEDEMA PERIPHERAL 43 0.0004
585 MUSCULAR WEAKNESS 40 0.0004
586 MYOCARDIAL ISCHAEMIA 4 0.0004
587 DERMATITIS CONTACT 4 0.0004
588 THERAPY CESSATION 18 0.0004
589 SPINAL FRACTURE 7 0.0003
590 MYOCARDITIS 4 0.0003
591 CARDIAC MURMUR 3 0.0003
592 DEVICE DEFECTIVE 6 0.0003
593 METABOLIC DISORDER 2 0.0003
594 DRUG WITHDRAWAL SYNDROME 30 0.0003
595 SPINAL PAIN 4 0.0003
596 COLD SWEAT 6 0.0003
597 COVID-19 PNEUMONIA 4 0.0003
598 ACCIDENT 4 0.0003
599 THERAPEUTIC PRODUCT EFFECT DECREASED 15 0.0003
600 OSTEOMYELITIS 6 0.0003
601 PALLOR 9 0.0003
602 BURSITIS 4 0.0003
603 ILL-DEFINED DISORDER 20 0.0003
604 VERTIGO 20 0.0003
605 NERVE COMPRESSION 3 0.0003
606 ABASIA 8 0.0003
607 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
608 DEVICE LEAKAGE 14 0.0003
609 DEVICE BREAKAGE 13 0.0003
610 INJECTION SITE IRRITATION 4 0.0003
611 ANGINA PECTORIS 9 0.0003
612 LETHARGY 18 0.0003
613 ACUTE RESPIRATORY FAILURE 6 0.0003
614 CARDIAC FAILURE 25 0.0003
615 ASTHENIA 117 0.0003
616 MUSCLE TIGHTNESS 5 0.0003
617 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
618 HAND DEFORMITY 4 0.0003
619 LOSS OF CONSCIOUSNESS 39 0.0003
620 TACHYCARDIA 27 0.0003
621 UPPER LIMB FRACTURE 6 0.0003
622 DYSURIA 11 0.0003
623 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
624 SUBARACHNOID HAEMORRHAGE 3 0.0003
625 MUSCLE SPASMS 54 0.0003
626 SLUGGISHNESS 3 0.0003
627 MOOD ALTERED 8 0.0003
628 PROSTATIC SPECIFIC ANTIGEN INCREASED 4 0.0003
629 MENTAL STATUS CHANGES 8 0.0003
630 DEVICE USE ERROR 10 0.0003
631 UNDERDOSE 21 0.0003
632 NERVOUSNESS 15 0.0003
633 DEHYDRATION 38 0.0003
634 HAND FRACTURE 2 0.0003
635 SUBDURAL HAEMATOMA 4 0.0003
636 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
637 C-REACTIVE PROTEIN INCREASED 10 0.0003
638 OESOPHAGITIS 3 0.0003
639 MAJOR DEPRESSION 2 0.0003
640 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 7 0.0003
641 CEREBRAL DISORDER 2 0.0003
642 FEELING DRUNK 2 0.0003
643 BACTERIAL INFECTION 5 0.0003
644 THROAT IRRITATION 12 0.0003
645 DYSPNOEA EXERTIONAL 10 0.0003
646 INTESTINAL OBSTRUCTION 10 0.0003
647 PAROSMIA 2 0.0003
648 PEMPHIGOID 2 0.0003
649 INTENTIONAL OVERDOSE 17 0.0003
650 COMPLETED SUICIDE 22 0.0003
651 PRODUCT AVAILABILITY ISSUE 6 0.0003
652 FEELING HOT 16 0.0003
653 DISSOCIATION 2 0.0003
654 SHOCK 6 0.0003
655 PROCEDURAL COMPLICATION 2 0.0003
656 DEATH 224 0.0003
657 THYROID DISORDER 4 0.0003
658 EMOTIONAL DISORDER 8 0.0003
659 DRUG INTOLERANCE 25 0.0003
660 RASH MACULAR 9 0.0003
661 DEVICE INFORMATION OUTPUT ISSUE 2 0.0003
662 HEART RATE DECREASED 9 0.0003
663 DEVICE DELIVERY SYSTEM ISSUE 7 0.0003
664 HYPOACUSIS 11 0.0003
665 KIDNEY INFECTION 5 0.0003
666 BLOOD ALBUMIN DECREASED 2 0.0003
667 THERAPY INTERRUPTED 18 0.0003
668 CHOLECYSTITIS 3 0.0003
669 MALAISE 110 0.0003
670 ATRIAL FLUTTER 2 0.0003
671 MYASTHENIA GRAVIS 2 0.0002
672 RESPIRATORY FAILURE 18 0.0002
673 INTENTIONAL DOSE OMISSION 7 0.0002
674 BODY TEMPERATURE INCREASED 5 0.0002
675 ASPHYXIA 2 0.0002
676 RESPIRATORY DEPRESSION 3 0.0002
677 LIVER INJURY 6 0.0002
678 VISUAL IMPAIRMENT 30 0.0002
679 ACUTE CORONARY SYNDROME 2 0.0002
680 HYPERTENSION 51 0.0002
681 RASH PRURITIC 13 0.0002
682 CONTUSION 23 0.0002
683 POISONING 3 0.0002
684 WITHDRAWAL SYNDROME 10 0.0002
685 KNEE ARTHROPLASTY 5 0.0002
686 MOUTH ULCERATION 5 0.0002
687 MUSCLE ATROPHY 3 0.0002
688 CARDIOVASCULAR DISORDER 6 0.0002
689 IRRITABILITY 14 0.0002
690 MUSCULOSKELETAL DISCOMFORT 4 0.0002
691 DRUG INEFFECTIVE 306 0.0002
692 MUSCLE STRAIN 2 0.0002
693 PYELONEPHRITIS 2 0.0002
694 ABDOMINAL DISTENSION 24 0.0002
695 PRODUCT PRESCRIBING ISSUE 5 0.0002
696 APPLICATION SITE ERYTHEMA 6 0.0002
697 BEDRIDDEN 3 0.0002
698 DECREASED APPETITE 53 0.0002
699 HOSPITALISATION 35 0.0002
700 TOOTH INFECTION 3 0.0002
701 SARS-COV-2 TEST POSITIVE 3 0.0002
702 FEAR 6 0.0002
703 PRODUCT TASTE ABNORMAL 3 0.0002
704 OROPHARYNGEAL DISCOMFORT 2 0.0002
705 DRUG EFFECT INCOMPLETE 8 0.0002
706 MOOD SWINGS 7 0.0002
707 CELLULITIS 11 0.0002
708 BRAIN NEOPLASM 2 0.0002
709 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
710 RHINORRHOEA 14 0.0002
711 ORAL DISCOMFORT 3 0.0002
712 PRODUCT DISTRIBUTION ISSUE 2 0.0002
713 COORDINATION ABNORMAL 3 0.0002
714 PLEURAL EFFUSION 13 0.0002
715 BLINDNESS UNILATERAL 3 0.0002
716 STAPHYLOCOCCAL INFECTION 7 0.0002
717 POST PROCEDURAL COMPLICATION 4 0.0002
718 AFFECT LABILITY 2 0.0002
719 HYPOAESTHESIA 31 0.0002
720 ADVERSE EVENT 19 0.0002
721 NAUSEA 163 0.0002
722 THROMBOCYTOPENIA 23 0.0002
723 INFLAMMATORY BOWEL DISEASE 2 0.0002
724 BLOOD PRESSURE INCREASED 31 0.0002
725 BACK PAIN 47 0.0002
726 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
727 CATARACT 12 0.0002
728 BLADDER DISORDER 2 0.0002
729 INABILITY TO AFFORD MEDICATION 2 0.0002
730 FATIGUE 155 0.0002
731 ABDOMINAL PAIN 46 0.0002
732 HAEMATEMESIS 5 0.0002
733 NECK PAIN 11 0.0002
734 INSURANCE ISSUE 3 0.0002
735 ACUTE KIDNEY INJURY 30 0.0002
736 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 35 0.0002
737 MUSCULOSKELETAL CHEST PAIN 3 0.0002
738 HAEMATOMA 5 0.0002
739 SWELLING 18 0.0002
740 POLLAKIURIA 8 0.0002
741 BRAIN FOG 3 0.0002
742 PARAESTHESIA 30 0.0002
743 VISION BLURRED 26 0.0002
744 RESPIRATORY TRACT CONGESTION 3 0.0002
745 OSTEOARTHRITIS 8 0.0002
746 CYSTITIS 6 0.0002
747 PALPITATIONS 22 0.0002
748 METABOLIC ACIDOSIS 6 0.0002
749 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 38 0.0002
750 BODY HEIGHT DECREASED 2 0.0002
751 DISEASE PROGRESSION 22 0.0002
752 HOT FLUSH 14 0.0002
753 DECREASED ACTIVITY 2 0.0002
754 BACK INJURY 2 0.0002
755 DYSPNOEA 103 0.0002
756 DRY EYE 9 0.0002
757 LIP SWELLING 6 0.0002
758 STEVENS-JOHNSON SYNDROME 4 0.0002
759 TOOTH DISORDER 4 0.0002
760 RENAL IMPAIRMENT 15 0.0002
761 FACE OEDEMA 3 0.0002
762 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
763 EYE INFECTION 2 0.0002
764 NEPHROLITHIASIS 8 0.0002
765 JOINT SWELLING 21 0.0002
766 PRODUCT SUBSTITUTION ISSUE 10 0.0002
767 CAESAREAN SECTION 2 0.0002
768 SURGERY 10 0.0002
769 PNEUMONIA 55 0.0002
770 ATAXIA 2 0.0002
771 BACTERAEMIA 2 0.0002
772 CEREBRAL HAEMORRHAGE 6 0.0002
773 PRODUCTIVE COUGH 8 0.0002
774 CRYING 6 0.0002
775 RENAL FAILURE ACUTE 7 0.0002
776 PAIN IN EXTREMITY 48 0.0002
777 FEMUR FRACTURE 5 0.0002
778 AGRANULOCYTOSIS 3 0.0002
779 SWOLLEN TONGUE 5 0.0002
780 PRODUCT USE ISSUE 30 0.0002
781 BLOOD URINE PRESENT 3 0.0002
782 DEVICE DEPLOYMENT ISSUE 2 0.0002
783 GASTROINTESTINAL DISORDER 14 0.0002
784 LOWER LIMB FRACTURE 3 0.0002
785 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
786 AMNESIA 10 0.0002
787 CEREBROVASCULAR ACCIDENT 26 0.0002
788 NODULE 2 0.0002
789 INFLUENZA 17 0.0002
790 SKIN DISCOLOURATION 7 0.0002
791 PULMONARY CONGESTION 2 0.0002
792 VOMITING 71 0.0002
793 RENAL FAILURE 20 0.0002
794 INTENTIONAL PRODUCT MISUSE 13 0.0001
795 TOXICITY TO VARIOUS AGENTS 25 0.0001
796 OEDEMA 8 0.0001
797 LIMB INJURY 4 0.0001
798 IMPAIRED GASTRIC EMPTYING 2 0.0001
799 PERIPHERAL COLDNESS 2 0.0001
800 TOOTH LOSS 3 0.0001
801 DRUG ABUSE 12 0.0001
802 APHONIA 2 0.0001
803 WOUND 4 0.0001
804 MASS 2 0.0001
805 OXYGEN SATURATION DECREASED 8 0.0001
806 INJURY 10 0.0001
807 HYPOXIA 5 0.0001
808 MYALGIA 24 0.0001
809 DIALYSIS 2 0.0001
810 OFF LABEL USE 123 0.0001
811 JOINT INJURY 3 0.0001
812 SKIN CANCER 3 0.0001
813 IMPAIRED QUALITY OF LIFE 2 0.0001
814 PARAESTHESIA ORAL 2 0.0001
815 INFECTION 20 0.0001
816 BLOOD CREATININE INCREASED 9 0.0001
817 FLUID RETENTION 7 0.0001
818 CHEST DISCOMFORT 14 0.0001
819 ATRIAL FIBRILLATION 13 0.0001
820 HEART RATE IRREGULAR 3 0.0001
821 HYPOAESTHESIA ORAL 2 0.0001
822 DEVICE FAILURE 2 0.0001
823 DISCOMFORT 8 0.0001
824 DRUG DISPENSING ERROR 2 0.0001
825 TINNITUS 6 0.0001
826 DRUG-INDUCED LIVER INJURY 4 0.0001
827 ARTHRITIS 10 0.0001
828 HAEMATOCHEZIA 7 0.0001
829 PULMONARY EMBOLISM 12 0.0001
830 NEUROPATHY PERIPHERAL 12 0.0001
831 PNEUMOTHORAX 2 0.0001
832 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
833 INJECTION SITE BRUISING 10 0.0001
834 ABDOMINAL DISCOMFORT 21 0.0001
835 LOCALISED INFECTION 3 0.0001
836 PAIN 76 0.0001
837 EYE DISORDER 4 0.0001
838 SEIZURE 14 0.0001
839 FUNGAL INFECTION 4 0.0001
840 CHEST PAIN 22 0.0001
841 WHEEZING 7 0.0001
842 CIRCULATORY COLLAPSE 2 0.0001
843 THERAPEUTIC RESPONSE DECREASED 7 0.0001
844 ANAEMIA 22 0.0001
845 RESPIRATORY TRACT INFECTION 3 0.0001
846 JOINT STIFFNESS 3 0.0001
847 HYPERKALAEMIA 4 0.0001
848 GASTRITIS 3 0.0001
849 PRODUCT USE IN UNAPPROVED INDICATION 28 0.0001
850 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
851 INJECTION SITE ERYTHEMA 14 0.0001
852 EAR INFECTION 3 0.0001
853 PRODUCT ADHESION ISSUE 4 0.0001
854 PROSTATE CANCER 9 0.0001
855 JAUNDICE 3 0.0001
856 GOUT 2 0.0001
857 HEART RATE INCREASED 11 0.0001
858 GASTROENTERITIS VIRAL 2 0.0001
859 DEPENDENCE 6 0.0001
860 RESPIRATORY ARREST 3 0.0001
861 BLOOD GLUCOSE ABNORMAL 2 0.0001
862 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
863 INJECTION SITE MASS 4 0.0001
864 BRONCHITIS 8 0.0001
865 MEDICATION ERROR 6 0.0001
866 CONJUNCTIVITIS 2 0.0001
867 DYSGEUSIA 8 0.0001
868 SWELLING FACE 7 0.0001
869 CARDIAC DISORDER 10 0.0001
870 OVERDOSE 23 0.0001
871 FLATULENCE 6 0.0001
872 ARRHYTHMIA 5 0.0001
873 FOOT FRACTURE 2 0.0001
874 HEADACHE 66 0.0001
875 RASH ERYTHEMATOUS 5 0.0001
876 HERNIA 2 0.0001
877 COVID-19 18 0.0001
878 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
879 ERYTHEMA 21 0.0001
880 NASAL CONGESTION 6 0.0001
881 COMPLICATION OF DEVICE INSERTION 2 0.0001
882 LACRIMATION INCREASED 3 0.0001
883 INTENTIONAL SELF-INJURY 2 0.0001
884 PRODUCT ADMINISTRATION ERROR 2 0.0001
885 EXTRA DOSE ADMINISTERED 4 0.0001
886 ABDOMINAL PAIN UPPER 20 0.0001
887 CARDIAC ARREST 8 0.0001
888 PERITONITIS 2 0.0001
889 INCORRECT DOSE ADMINISTERED 22 0.0001
890 DIARRHOEA 62 0.0001
891 CARDIO-RESPIRATORY ARREST 4 0.0001
892 DERMATITIS 2 0.0001
893 WEIGHT INCREASED 21 0.0001
894 PRURITUS 36 0.0001
895 NIGHT SWEATS 3 0.0001
896 DRUG EFFECT DECREASED 5 0.0001
897 DEVICE EXPULSION 6 0.0001
898 FAECES DISCOLOURED 2 0.0001
899 SEPTIC SHOCK 4 0.0001
900 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
901 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
902 CHOLELITHIASIS 3 0.0001
903 INJECTION SITE SWELLING 7 0.0001
904 APPLICATION SITE PAIN 2 0.0001
905 SEPSIS 10 0.0001
906 GLOSSODYNIA 2 0.0001
907 PULMONARY OEDEMA 4 0.0001
908 ORAL PAIN 2 0.0001
909 PANCREATITIS ACUTE 2 0.0001
910 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
911 ILLNESS 9 0.0001
912 OROPHARYNGEAL PAIN 8 0.0001
913 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
914 BURNING SENSATION 6 0.0001
915 CHILLS 10 0.0001
916 OCULAR HYPERAEMIA 4 0.0001
917 PYREXIA 29 0.0001
918 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
919 ACCIDENTAL OVERDOSE 3 0.0001
920 LUNG DISORDER 4 0.0001
921 DYSPEPSIA 8 0.0001
922 EXTRAPYRAMIDAL DISORDER 2 0.0001
923 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
924 RASH 35 0.0001
925 EPISTAXIS 6 0.0001
926 ABDOMINAL PAIN LOWER 2 0.0001
927 NEOPLASM MALIGNANT 5 0.0001
928 CARDIAC FAILURE CONGESTIVE 6 0.0001
929 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
930 EMOTIONAL DISTRESS 9 0.0001
931 PAIN OF SKIN 2 0.0001
932 FREQUENT BOWEL MOVEMENTS 2 0.0001
933 BLINDNESS 3 0.0001
934 OSTEOPOROSIS 3 0.0001
935 DEVICE MALFUNCTION 5 0.0001
936 PAIN IN JAW 2 0.0001
937 HERPES ZOSTER 4 0.0001
938 FLUSHING 7 0.0001
939 MYOCARDIAL INFARCTION 12 0.0001
940 ACUTE MYOCARDIAL INFARCTION 2 0.0001
941 LIVER DISORDER 3 0.0001
942 ARTHRALGIA 28 0.0001
943 BLOOD POTASSIUM DECREASED 2 0.0001
944 HEPATIC FAILURE 2 0.0001
945 CHRONIC KIDNEY DISEASE 5 0.0001
946 INJECTION SITE RASH 2 0.0001
947 RENAL DISORDER 3 0.0001
948 EXPOSURE DURING PREGNANCY 4 0.0001
949 DISEASE RECURRENCE 3 0.0001
950 BLOOD GLUCOSE DECREASED 3 0.0001
951 THROMBOSIS 5 0.0001
952 ALOPECIA 12 0.0001
953 LEUKOPENIA 3 0.0001
954 DRY SKIN 8 0.0001
955 NASOPHARYNGITIS 11 0.0001
956 HAEMATURIA 2 0.0001
957 GASTRIC DISORDER 2 0.0001
958 INFLAMMATION 3 0.0001
959 DRUG DOSE OMISSION 9 0.0001
960 BLISTER 3 0.0001
961 EYE PAIN 3 0.0001
962 COLITIS 2 0.0001
963 DIABETES MELLITUS 4 0.0001
964 NEUTROPENIA 7 0.0001
965 PLASMA CELL MYELOMA 2 0.0001
966 SINUSITIS 5 0.0000
967 HAEMOGLOBIN DECREASED 5 0.0000
968 HAEMORRHAGE 5 0.0000
969 RECTAL HAEMORRHAGE 2 0.0000
970 INFUSION RELATED REACTION 3 0.0000
971 HEPATIC ENZYME INCREASED 3 0.0000
972 INJECTION SITE REACTION 3 0.0000
973 BREAST CANCER 4 0.0000
974 MULTIPLE SCLEROSIS 2 0.0000
975 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
976 ECZEMA 2 0.0000
977 MUSCULOSKELETAL PAIN 2 0.0000
978 INJECTION SITE HAEMORRHAGE 3 0.0000
979 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
980 ASTHMA 4 0.0000
981 CONVULSION 2 0.0000
982 INJECTION SITE PAIN 10 0.0000
983 HYPERSENSITIVITY 6 0.0000
984 BLOOD GLUCOSE INCREASED 6 0.0000
985 MIGRAINE 3 0.0000
986 DRUG DEPENDENCE 5 0.0000
987 DEEP VEIN THROMBOSIS 2 0.0000
988 PSORIASIS 4 0.0000
989 FEBRILE NEUTROPENIA 2 0.0000
990 INJECTION SITE PRURITUS 2 0.0000
991 PRODUCT QUALITY ISSUE 4 0.0000
992 NO ADVERSE EVENT 3 0.0000